Citation 127667

MIYAMOTO,KI: MURAYAMA,T: NOMURA,M: HATANO,KT: YOSHIDA,T: FURUKAWA,T: KOSHIURA,R: OKUDA,T:. (1993). ANTITUMOR ACTIVITY AND INTERLEUKIN-1 INDUCTION BY TANNINS.. 13(1)

Citation Details

Title	ANTITUMOR ACTIVITY AND INTERLEUKIN-1 INDUCTION BY TANNINS.
Authors	MIYAMOTO,KI: MURAYAMA,T: NOMURA,M: HATANO,KT: YOSHIDA,T: FURUKAWA,T: KOSHIURA,R: OKUDA,T:
Year	1993
Volume	13
Issue	1

Summary

Year: 1993

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CATECHIN-3-O-GALLATE,EPI: (-):	INACTIVE
2	INTERLEUKIN-1 FORMATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	CATECHIN-3-O-GALLATE,EPI: (-):	INACTIVE
3	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GALLOCATECHIN-3-O-GALLATE,EPI: (-):	INACTIVE
4	INTERLEUKIN-1 FORMATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	GALLOCATECHIN-3-O-GALLATE,EPI: (-):	INACTIVE
5	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TELLIMAGRANDIN I	INACTIVE
6	INTERLEUKIN-1 FORMATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELLIMAGRANDIN I	WEAK ACTIVITY
7	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TELLIMAGRANDIN II	ACTIVE
8	INTERLEUKIN-1 FORMATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELLIMAGRANDIN II	WEAK ACTIVITY
9	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CASUARICTIN	INACTIVE
10	INTERLEUKIN-1 FORMATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	CASUARICTIN	WEAK ACTIVITY
11	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RUGOSIN A	WEAK ACTIVITY
12	INTERLEUKIN-1 FORMATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	RUGOSIN A	WEAK ACTIVITY
13	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LAEVIGATIN B	INACTIVE
14	INTERLEUKIN-1 FORMATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	LAEVIGATIN B	INACTIVE
15	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	AGRIMONIIN	ACTIVE
16	INTERLEUKIN-1 FORMATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	AGRIMONIIN	ACTIVE
17	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LAEVIGATIN C	INACTIVE
18	INTERLEUKIN-1 FORMATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	LAEVIGATIN C	INACTIVE
19	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HIRTELLIN B	ACTIVE
20	INTERLEUKIN-1 FORMATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	HIRTELLIN B	ACTIVE
21	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	EUPHORBIN A	INACTIVE
22	INTERLEUKIN-1 FORMATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	EUPHORBIN A	INACTIVE
23	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	EUMACULIN A	INACTIVE
24	INTERLEUKIN-1 FORMATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	EUMACULIN A	INACTIVE
25	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	EUPHORBIN C-HY	INACTIVE
26	INTERLEUKIN-1 FORMATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	EUPHORBIN C-HY	INACTIVE
27	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	OENANTHEIN A	INACTIVE
28	INTERLEUKIN-1 FORMATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	OENANTHEIN A	INACTIVE
29	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	OENANTHEIN B	ACTIVE
30	INTERLEUKIN-1 FORMATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	OENANTHEIN B	ACTIVE

Citation 127667

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1